Body

Medication slows progression of myopia in children

Philadelphia, PA, August 26, 2008 – Daily treatment with a medication called pirenzepine can slow the rate of progressive myopia, or nearsightedness, in children, reports a study in the August issue of the Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).

Caesarean babies more likely to develop diabetes

Babies delivered by Caesarean section have a 20 per cent higher risk than normal deliveries of developing the most common type of diabetes in childhood, according to a study led by Queen's University Belfast.

The team, led by Dr Chris Cardwell and Dr Chris Patterson, examined 20 published studies from 16 countries including around 10,000 children with Type 1 diabetes and over a million control children.

Molecular cubes in the sunlight

This press release is also available in German.

Bones get mended with high tech glass-of-milk

Scientists at the new Nuclear-Magnetic Resonance unit at the University of Warwick have discovered how a high tech glass of milk is helping bones mend.

Low temperature Bioglass is used to help fix broken bones, but until now no-one has been able to understand the process.

Using a strong magnetic field to 'see' into the bones researchers saw calcium rush into the bioglass in the first hour of implantation.

Cell removal technique could lead to cheaper drugs

Researchers at the University of Edinburgh have pioneered a simple way to remove dead cells from cell cultures used to make protein-based drugs, which are increasingly prescribed to treat a range of illnesses.

Such medicines are expensive to make, with high costs resulting from the time-consuming and labour-intensive nature of developing them in cell culture

New findings explain genetic disorder's unique shift

KNOXVILLE -- Findings reported in this month's issue of PLoS Biology give insight into the unique characteristics of the birth defect known as Prader-Willi Syndrome (PWS), and at the same time, may help explain the way that a certain type of gene is expressed in all humans.

The research by University of Tennessee, Knoxville, professor Francisco Ubeda finds that the amount of care a father gives to his child may cause a shift in the syndrome in which its symptoms, in essence, reverse themselves.

Explaining a genetic disorder's unique shift

Findings reported in this week's PLoS Biology give insight into the unique characteristics of the birth defect known as Prader-Willi Syndrome (PWS), and at the same time, may help explain the way that a certain type of gene is expressed in all humans.

The research by University of Tennessee, Knoxville, professor Francisco Ubeda finds that the amount of care a father gives to his child may cause a shift in the syndrome in which its symptoms, in essence, reverse themselves.

How does bluetongue virus survive through the winter?

In 2006, Bluetongue virus – which infects livestock – reached Northern Europe for the first time. Some people thought that the outbreak would be limited to that particular year, as winter was expected to kill off the midges that host and spread the disease, bringing the threat of infection to an end. In actuality, the disease escalated in the following year, spreading to the UK. So, how did the virus survive the winter?

Providing surgical services worldwide should be a global public health priority

In an editorial in this week's PLoS Medicine, the journal's editors outline five key reasons why providing basic surgical services universally should be considered a global public health priority:

Infections linked to premature births more common than thought, Stanford study finds

STANFORD, Calif. - Previously unrecognized and unidentified infections of amniotic fluid may be a significant cause of premature birth, according to researchers at the Stanford University School of Medicine.

An analysis of amniotic fluid from women in preterm labor indicated that 15 percent of the fluid samples harbored bacteria or fungi - an increase of 50 percent over previous estimates. The heavier the burden of infection, the more likely the women were to deliver younger, sicker infants.

California tobacco control program saved billions in medical costs

California's state tobacco control program saved $86 billion--in 2004 dollars--in personal healthcare costs in its first 15 years, according to a study by researchers at the University of California, San Francisco.

During the same period, the state spent only a total of $1.8 billion on the program, a 50-to-1 return on investment, according to study findings. The study is the first that has been able to quantifiably connect tobacco control to healthcare savings, say its authors.

Study: DNA barcoding in danger of 'ringing up' wrong species

Provo, Utah – DNA barcoding is a movement to catalog all life on earth by a simple standardized genetic tag, similar to stores labeling products with unique barcodes. The effort promises foolproof food inspection, improved border security, and better defenses against disease-causing insects, among many other applications.

Century-old rule of chemistry overturned -- major implications for drug delivery

A new study by research chemists at the University of Warwick has challenged a century old rule of pharmacology that defined how quickly key chemicals can pass across cell walls. The new observations of the Warwick researchers suggest that the real transport rates could be up to a hundred times slower than predicted by the century old "Overton's Rule". This could have major implications for the development and testing of many future drugs.

Potential diabetes treatment selectively kills autoimmune cells from human patients

In experiments using blood cells from human patients with diabetes and other autoimmune disorders, Massachusetts General Hospital (MGH) researchers have confirmed the mechanism behind a potential new therapy for type 1 diabetes. A team led by Denise Faustman, MD, PhD, director of the MGH Immunobiology Laboratory, showed that blocking a metabolic pathway regulating the immune system specifically eliminated immune cells that react against a patient's own tissues.

Looking beyond the drug receptor for clues to drug effectiveness

DURHAM, N.C. – Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes in how these drugs are developed and prescribed.